Medical
Clariant establishes global medical and pharmaceutical segment within Masterbatches BU
Feb 9, 2011
Announced on Medical Design & Manufacturing (MD&M) West show which started yesterday (February 8) in Anaheim, California, the US, Clariant, a global specialty chemical company, has established a global Medical and Pharmaceutical segment within its Masterbatches Business Unit to further strengthen its support for customers in these highly demanding markets.
Headed by Stephen Duckworth, the new group will manage the development, production, marketing and technical support for Clariant's MEVOPUR color masterbatches and custom performance compounds, which are manufactured exclusively for medical and pharmaceutical applications. The MEVOPUR brand is produced under specially controlled conditions at three dedicated global ISO13485 certified sites located in Lewiston, Maine in the US, Malmö in Sweden and in Singapore.
Clariant said the formation of this sector-specific organization demonstrates its commitment to provide application knowledge and product expertise tailored to the specific requirements and challenges of the medical device and pharmaceutical packaging industries. In particular, it will support customers in meeting the increasingly strict controls governing end-product ingredients and manufacturers' need to minimize risk at every stage of design, production and product approval.
According to the manufacturer, the MEVOPUR-branded color masterbatches, pre-colored compounds, standard color ranges and performance-enhancing solutions are produced under controlled, consistent and compliant conditions to help customers achieve appearance and performance enhancement for their medical device or packaging application while ensuring regulatory acceptability. MEVOPUR uses raw materials that have been biologically evaluated against USP parts 87 and 88 (Class VI devices) and/or the international standard ISO10993. Segregated manufacturing lines help reduce the risk of cross contamination, and segregated storage and change-control processes ensure consistency.
Headed by Stephen Duckworth, the new group will manage the development, production, marketing and technical support for Clariant's MEVOPUR color masterbatches and custom performance compounds, which are manufactured exclusively for medical and pharmaceutical applications. The MEVOPUR brand is produced under specially controlled conditions at three dedicated global ISO13485 certified sites located in Lewiston, Maine in the US, Malmö in Sweden and in Singapore.
Clariant said the formation of this sector-specific organization demonstrates its commitment to provide application knowledge and product expertise tailored to the specific requirements and challenges of the medical device and pharmaceutical packaging industries. In particular, it will support customers in meeting the increasingly strict controls governing end-product ingredients and manufacturers' need to minimize risk at every stage of design, production and product approval.
According to the manufacturer, the MEVOPUR-branded color masterbatches, pre-colored compounds, standard color ranges and performance-enhancing solutions are produced under controlled, consistent and compliant conditions to help customers achieve appearance and performance enhancement for their medical device or packaging application while ensuring regulatory acceptability. MEVOPUR uses raw materials that have been biologically evaluated against USP parts 87 and 88 (Class VI devices) and/or the international standard ISO10993. Segregated manufacturing lines help reduce the risk of cross contamination, and segregated storage and change-control processes ensure consistency.
原创,请勿转载
Specials
Medical
Clariant
Masterbatch
ZHEJIANG JINTENG MACHINERY MANUFCTURE CO.,LTD
NANJING GRANUWEL MACHINERY CO., LTD.
Zhangjiagang Shengrong Co., Ltd.
Jiangxi D-Ray New Material Co., Ltd
TAIZHOU HONYEU MACHINERY CO., LTD.
CHINA KWM PLASTIC MOLD CO.,LTD
Suzhou Detech Automation Technology Co.,Ltd.
WUXI MAICO MACHINERY CO.,LTD.
GUANGDONG GUANGCE INSTRUMENT TECHNOLOGY CO., LTD.
Comments
Specials
Chemicals
At FAKUMA 2026, Sun Chemical will present its latest innovations for engineering plastics, sustainability and advanced material solutions.
Sep 15, 2026
Chemicals
Clariant has been awarded a contract by Zhejiang Petroleum & Chemical to supply its CATOFIN catalyst and Heat Generating Material (HGM) for a new propane dehydrogenation (PDH) unit in Zhejiang, China.
Sep 15, 2026
Corporate News
The milestone marks a significant advancement in Clariant's local innovation capability and its commitment to the “In China, For China” strategy.
Aug 20, 2026
Corporate News
Clariant appoints Gapuma Group as a distributor of its Well Service Additives (WSA) portfolio across West Africa – Nigeria, Côte d'Ivoire, and Ghana.
Jul 31, 2026
Packaging
Silken Stone, a new special effects masterbatch for beauty, personal care, and fabric care packaging, delivers an understated elegance of marble with a refined, subtle luster.
Jul 31, 2026
Chemicals
Clariant increases the capacity of sustainable flame-retardant solutions in its Daya Bay facility in China with CHF 100 million investment, with the second production line fully operational in November.
Jun 22, 2026